Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Sensus Healthcare Inc (SRTS)
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
$3.25-1.22%
Close 2026-11-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for SRTS yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain access to credit facility and liquidity | The company has a new credit facility to support operations. | Intact | Loss of credit facility or liquidity crisis | Credit facility $15.0M active June 2026 8-K confirms new $15.0M revolving credit facility with City National Bank of Florida. Nov 4, 2026Last status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 12, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earningsObserved price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a speculative growth business with fragile earnings quality, weak recent performance, and high risk. Its multi-year thesis is on watch: management is pursuing customer adoption and recurring revenue, but the latest signal has turned cautious.
SRTS is described as cheap versus peers, and the evidence says weak execution quality is reflected in the current setup rather than a broader stack of expensive valuation and turbulence. The expectations gap is negative, so the valuation evidence does not point to strong room for execution to fall short.
Near term, results may remain uneven: revenue fell from $3.4 million in the first quarter of 2026 to $2.3 million in the second, and the company has had consecutive earnings misses. Over the multi-year view, treatment volumes under the Fair Deal Agreement program are growing and dedicated CPT codes have supported physician engagement, but customer adoption and revenue growth remain mixed.
A guidance cut on the next call or further weakening in jobs data could add pressure to an already fragile near-term setup. Continued adoption, growth in recurring treatment volumes, and supportive results from healthcare bellwethers would strengthen the multi-year case.
Over the next 1 to 3 years, the thesis depends on commercial progress becoming more consistent reported growth, while the next quarter carries elevated miss risk. The current evidence supports a cautious watch, not a settled growth record. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| A primary condition in Sensus Healthcare Inc's published investment case. The stated target is EPS >= -$0.02 per share. |
| Under Pressure |
| EPS remains below -$0.02 per share in FY27 |
Diluted EPS: $-0.53 per share FY2026-Q2; GAAP. Published target: EPS >= -$0.02 per share. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 2026-0.53 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Revenue at or above $27.5 million in FY26 | Sensus Healthcare aims to grow revenue above $27.5 million in 2026. | Broken | Revenue falls below $27.5 million in FY26 | Revenue: $2.29M FY2026-Q2; GAAP. Published target: >= $27.5 million. Annual target cannot be compared with a quarterly or TTM observation. Aug 14, 20262,290,000 USD · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$-0.09 → $-0.11 · observed estimates
$0.03B → $0.03B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-07-25 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-07-26 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-07-27 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-07-28 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-07-29 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-07-30 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-07-31 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-01 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-02 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-03 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-04 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-05 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-06 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-08 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-09 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-10 | $-0.09 | $31,335,500 | 3 / 4 |
| 2026-08-12 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-13 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-14 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-15 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-16 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-17 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-18 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-19 | $-0.12 | $31,335,500 | 3 / 4 |
| 2026-08-20 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-21 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-22 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-23 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-24 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-25 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-26 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-27 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-28 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-29 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-30 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-08-31 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-01 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-02 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-03 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-04 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-05 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-06 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-07 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-08 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-09 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-10 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-11 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-12 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-13 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-14 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-15 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-16 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-17 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-18 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-19 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-20 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-21 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-22 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-23 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-24 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-25 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-26 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-27 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-28 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-29 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-09-30 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-01 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-02 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-03 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-04 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-05 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-06 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-07 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-08 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-09 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-10 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-11 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-12 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-13 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-14 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-15 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-16 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-17 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-18 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-19 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-20 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-21 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-22 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-23 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-24 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-25 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-26 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-27 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-28 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-29 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-30 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-10-31 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-11-01 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-11-02 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-11-03 | $-0.11 | $28,185,750 | 3 / 4 |
| 2026-11-04 | $-0.11 | $28,185,750 | 3 / 4 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 4 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 6–Nov 4 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
2 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.